Ryanodex Injection, Suspension
Product Images NDC 42367-540

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ryanodex (NDC 42367-540). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eagle Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ryanodex 01

Chemical structure of dantrolene sodium, the active ingredient in RYANODEX dantrolene sodium injection, suspension 250 mg/5 mL. The diagram shows the molecular arrangement including aromatic rings, nitro, and sodium salt groups.*

FDA Label Image

Ryanodex 02

Packaging label for RYANODEX dantrolene sodium injectable suspension, 250 mg per vial, marketed by Eagle Pharmaceuticals, Inc. This label includes dosage instructions, storage information, and barcode. The product is for intravenous use only, supplied as a single-dose vial. The label highlights the reconstitution yield of 50 mg/mL and instructions to use sterile water for injection.*

FDA Label Image

Ryanodex 03

RYANODEX dantrolene sodium 250 mg per vial injectable suspension label for intravenous use. The label indicates a single-dose vial containing 250 mg of dantrolene sodium with reconstitution yielding 50 mg/mL. It also includes storage instructions, manufacturer Eagle Pharmaceuticals, Inc., and the product NDC 42367-540-32.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.